Pre-operative circulating carcinoembryonal antigen in primary breast cancer: Review of the literature and personal experience on 150 cases

Breast

Volumn 5, Issue 1, 1996, Pages 37-40

  Cartei, G ^a,e   Cartei, F ^b   Interlandi, G ^c   Barbagiovanni, R ^c   Meneghini, G ^c   Imperato, A ^d   Tabaro, G ^a  

^a Cancer Center   (Italy)

^b Azienda Ospedaliera   (Italy)

^c Azienda Ospedaliera S Chiara   (Italy)

^d Oncology Service   (Italy)

^e SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0030032369     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(96)90047-8     Document Type: Article

References (42)

1. Shively J E, Beatty J D. CEA-related antigens: molecular biology and clinical significance. CRC Crit Rev Oncol Hematol 1985; 2: 355-399.
2. Fantini G A, De Cosse J J. Surveillance strategies after resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1990; 171: 267-273.
3. National Institute of Health Consensus Development Conference. Carcinoembryonic antigen: its role as a marker in the management of cancer. Ann Intern Med 1981; 94: 407-409.
4. Bates S E, Long D C. Use of serum tumor markers in cancer diagnosis and management. Serum Oncol 1987; 14: 102-138.
5. Mansour E G, Hastert M, Park C H et al. Tissue and plasma carcinoembryonic antigen in early breast cancer. A prognostic factor. Cancer 1983; 51: 1243-1248.
6. Walker R A. Demonstration of carcinoembryonic antigen in human breast carcinomas by the immunoperoxidase technique. J Clin Pathol 1980; 33: 356-360.
7. Smith S R, Howell A, Minawa A, Morrison J M. The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy. Br J Cancer 1982; 46: 757-764.
8. Dixon J M, Anderson T J, Page D L et al. Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg 1983; 70: 513-516.
9. Papotti M, Gugliotta P, Eusebi V, Bussolati G. Immunohistochemical analysis of benign and malignant papillary lesions of the breast. Am J Surg Pathol 1983; 7: 451-461.
10. Halter S A, Fraker L D, Parmenter M, Dupont W D. Carcinoembryonic antigen expression and patient survival in carcinoma of the breast. Oncology 1984; 41: 297-302.
11. Lee A K, DeLellis R A, Rosen P P et al. Alphalactalbumin as an immunohistochemical marker for metastatic breast carcinomas. Am J Surg Pathol 1984; 8: 93-100.
12. Gilchrist K W, Kalish L, Gould V E et al. Immunostaining for carcinoembryonic antigen does not discriminate for early recurrence in breast cancer. The ECOG experience. Cancer 1985; 56: 351-355.
13. Nesland J M, Holm R, Johannessen J V. Ultrastructural and immunohistochemical features of lobular carcinoma of the breast. J Pathol 1985; 145: 39-52.
14. Gent H, Harpprecht J, Rodewald G, Muller-Ruchholtz W. Quantitative analysis of carcinoembryonic antigen (CEA) in fresh tissue specimens of the mammary gland. ARZTL-LAB 1987; 33/12; 290-295.
15. Robertson J F R, Ellis I O, Bell J et al. Carcinoembryonic antigen immunohistochemistry in primary breast carcinoma. Cancer 1989; 64: 1638-1645.
16. Steward A M, Nixon D, Zamcheck N, Aisenberg A. Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. Cancer 1974; 33: 1246-1252.
17. Tormey D C, Waalkes T P, Ahmann D et al. Biological markers in breast carcinoma-I. Incidence of abnormalities of CEA, HCG, three polyamines and three minor nucleosides. Cancer 1975; 35: 1095-1100.
18. Coombes R C, Powles T J, Gazet J C et al. A biochemical approach to the staging of human breast cancer. Cancer 1977; 40: 937-944.
19. Myers R E, Sutherland D J, Meakin J W, Kellen J A, Malkin D G, Malkin A. Carcinoembryonic antigen in breast cancer. Cancer 1978; 42: 1520-1526.
20. Varnavides L A, O'Higgins N J, Clark C G. Carcinoembryonic antigen (CEA) in mammary disease: a clinical evaluation. Clin Oncol 1978; 4: 329-337.
21. Wahren B, Lidbrink E, Wallgren A, Eneroth P, Zajicek J. Carcinoembryonic antigen and other tumor markers in tissue and serum or plasma of patients with primary mammary carcinoma. Cancer 1978; 42: 1870-1878.
22. Rimsten A, Adami H O, Wahren B, Nordin B. Carcinoembryonic antigen in serum of unselected breast cancer patients and of non-hospitalized controls. Br J Cancer 1979; 39: 109-115.
23. Beatty J D, Romero C, Brown P W, Lawrence W, Trez J J. Clinical value of Carcinoembryonic Antigen. Arch Surg 1979; 114: 563-567.
24. Hogan-Ryan A, Fennelly J J, Jones M, Cantwell B, Duffy M J. Serum sialic acid and CEA concentrations in human breast cancer. Br J Cancer 1980; 41: 587-592.
25. Bezwoda W, Derman D, Bothwell T, MacPhil P, Levin J, De Moor N. Significance of serum concentration of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer. Cancer 1981; 48: 1623-1628.
26. Lee Y. Carcinoembryonic antigen as a monitor of recurrent breast cancer. J Surg Oncol 1982; 20: 109-114.
27. Eskelinen M, Metsa-Ketela T, Valkamo E, Collan Y. Measurement of serum CEA in breast disease: use in the diagnostic and therapeutic protocol of breast tumors. J Tumor Marker Oncol 1988; 3: 399-405.
28. Krebs B, Turchi P, Bonet C, Schneider M, Lalanne C M, Namer N. Carcino-embryonic antigen assay in breast and bronchus cancers. Europ J Cancer 1977; 13: 375-376.
29. Haagensen D E, Kister S J, Vandevoorde J P et al. Evaluation of carcinoembryonic antigen as a plasma monitor for human breast cancer. Cancer 1978; 42: 1512-1519.
30. Doyle P J, Nicholson R I, Groome G V, Blarney R W. Carcinoembryonic antigen (CEA): its role as a tumour marker in breast cancer. Clin Oncol 1981; 7: 53-58.
31. Lepera P, Valtolina M, Cocciolo M E et al. A preliminary evaluation of CEA and TPA clinical value in an ongoing trial on patients with operable breast cancer. J Nucl Med Allied Sc 1985; 29: 97-98.
32. Ovaleo-Pandolfo E, Capelli P, Franciosi V. Diagnostic and prognostic unreliability of pre- and postoperative CEA in breast cancer patients. Acta Biomed Ateneo Parmense 1985; 56: 91-98.
33. Theriault R L, Hortobagyi G N, Fritsche H A, Frye D, Martinez R, Buzdar A U. The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy. Cancer 1989; 63: 828-835.
34. Safi F, Kohler I, Röttinger E, Beger H G. The value of the tumor marker CA15-3 in the diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen. Cancer 1991; 68: 574-582.
35. Thompson J, Zimmermann. The carcinoembryonic antigen gene family: structure, expression and evolution. Tumor Biol 1988; 9: 63-70.
36. Beard D B, Haskell C M. Carcinoembryonic antigen in breast cancer. Am J Med 1986; 80: 241-245.
37. Horn Y, Hacohen D, Zeidman J L et al. Carcinoembryonic antigen and interferon as tumor markers in breast cancer. J Surg Oncol 1983; 22: 254-256.
38. Zwirner M, Staab H J, Brummendorf T, Pillar M, Schindler A E. A comparison of CEA and TPA in mammary carcinoma using different assay sistem. Biennal International Breast Cancer Research Conference. London, March 24-28, 1985. Imperial Cancer Research Fund, p. 128, 1985.
39. Colomer R, Ruibal A, Salvador L. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease. Cancer 1989; 64: 1674-1681.
40. Von Kleist S, Bombardiert E, Buraggi G et al. Immunodiagnosis of tumours. Eur J Cancer 1993; 29A: 1622-1630.
41. Guzman J, Costabel U, Bross K J, Wiehle U, Grunert F, Schaefer H E. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer. Acta-Cytol 1988; 32: 188-192.
42. Grzanka A, Cetnarowski L, Domaniewski J. Relation between ultrastructural presence of CEA using peroxidase-antiperoxidase (PAP) method and tissue and serum levels of CEA in patients with breast cancer. Folia Histch Cytobiol 1991; 29: 131-134.